Pregnant women thought to be experiencing cardiac ischemia are treated the same as nonpregnant patients, with the exception of thrombolytic therapy. Pregnancy is considered a relative contraindication to thrombolytic therapy by the American College of Cardiology/American Heart Association. 16 No controlled trials using thrombolytic agents, such as streptokinase, urokinase, or tissue plasminogen activator, have been performed on pregnant women or are currently feasible. Patients with suspected myocardial infarction should be evaluated for emergent percutaneous interventional therapy or medical management.
Was this article helpful?